Biotech Growth Trust (the) Plc

Biotech Growth (BIOG)

Buy
Sell
Company name:Biotech Growth Trust (the) Plc
EPIC:BIOGTrading Currency:GBX
Market Sector:SSC5ISIN:GB0000385517
Market Segment:SSMMShare Type:DE
WWW Address:https://www.biotechgt.com/Description:ORD 25P
Industry Sector:EQUITY INVESTMENT INSTRUMENTS
 Price Price Change [%] Bid Offer Open High Low Volume
 1,480.00 images.advfn.com/imagesnew/2/gb/up 22.0 [1.51] 1,466.00 1,480.00 1,480.00 1,480.00 1,480.00 7,044
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 597.10 40.34 -0.15 1.00 - 1,480.00 - 1,518.00 - 680.00

Biotech Growth Key Figures

(at previous day's close)
Market Cap.597.10m
Shares In Issue40.34m
Prev. Close1,458.00
PE Ratio1,480.00 
Dividend Yield-%
EPS - basic1.00p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-9.33p
Return On Equity (ROE)0.13%
Operating Margin50.42%
PEG Factor- 
EPS Growth Rate-%
Dividends PS Growth Rate-%
Net Debt35.62m
Gross Gearing8.88%
Quick Assets2.53m
Net Working Capital-33.08m
Intangibles / Fixed Assets-%
Turnover PS3.25p
Pre-Tax Profit PS1.64p
Retained Profit PS1.16p
Cash PS-p
Net Cash PS-88.28p
Net Tangible Asset Value PS *906.12p
Net Asset Value PS932.40p
Spread14.00 (0.95%) 

Biotech Growth Balance Sheet

LSE:BIOG:Liabilities+EQLSE:BIOG:Assets

Share Price Performance

Sample Period HighLow
1 week1,494.001,432.00
4 weeks1,510.001,350.00
12 weeks1,518.001,160.00
1 year1,518.00680.00

Share Price Chart (5 years)

Biotech Growth Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week1,458.0022.001.511,432.000.121,461.95
4 weeks1,378.00102.007.401,350.000.091,439.54
12 weeks1,248.00232.0018.591,160.000.081,402.70
26 weeks1,210.00270.0022.311,060.000.091,311.90
1 year796.00684.0085.93680.000.111,079.48
3 years802.00678.0084.54596.000.10873.94
5 years718.00762.00106.13520.000.09809.77

Biotech Growth Key Management Ratios

Biotech Growth Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio1,480.00 
Tobin's Q Ratio 1.43 
Tobin's Q Ratio (excl. intangibles)1.43 
Dividend Yield-%
Market-to-Book Ratio1.63 
Price-to-Pre-Tax Profit PS901.97 
Price-to-Retained Profit PS1,281.34 
Price-to-Cash Flow PS-158.59 
Price-to-Sales PS454.76 
Price-to-Net Tangible Asset Value PS1.59 
Price-to-Cash PS- 
Net Working Capital PS-82.00 
Price Pct to Working Capital PS-18.05%
Earnings Yield0.07%
Average PE620.74 
Years in average5 
PE to PE average238.43%

Biotech Growth Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing8.88%
Net Gearing (excl. Intangibles)8.88%
Gross Gearing8.88%
Gross Gearing (excl. Intangibles)8.88%
Gearing Under 1 Year8.88%
Gearing Under 1 Year (excl. Intgbl)8.88%
Assets/Equity1.10 
Cash/Equity- 
(Liquidity Ratios)
Net Working Capital to Total Assets-8.25%
Current Ratio0.07 
Quick Ratio (Acid Test)0.07 
Liquidity Ratio- 
Cash & Equiv/Current Assets-%
(Solvency Ratios)
Enterprise Value597.10m
CFO/Sales-2.87 
CFO/Attributable Profit- 
CFO/Assets-0.01 
CFO/Debt-0.11 
Total Debt/Equity Market Value0.06 
Total Debt/Sales27.13 
Total Debt/Pre-Tax Profit53.80 
Total Debt35.62m
Total Debt/Net Current Assets-1.08%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs7 
Beta (60-Mnth)Beta (36-Mnth)
-0.1547-0.4080

Biotech Growth Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)0.18%
Return On Assets (ROA)0.11%
Net Profit Margin35.49%
Assets Turnover0.00 
Return On Equity (ROE)0.13%
Return On Investment (ROI)0.12%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio0.12%
Net Income Of Revenues35.49%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.00 
Fixed Assets Turnover0.00 
Current Assets Turnover1.01 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales316.99 
Debtors-to-Sales98.71%
Debt Collection Period360.27Days

Biotech Growth Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
20 Jun 2001FinalGBP0.2031/03/200031/03/200104/07/200106/07/200130/07/20010.20

Biotech Growth Fundamentals

 31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)
turnover1.91100.00%1.58100.00%1.25100.00%1.31100.00%m
pre tax profit1.2063.10%0.8453.11%0.7056.26%0.6650.42%m
attributable profit0.9248.35%0.6038.01%0.5241.33%0.4735.49%m
retained profit0.9248.35%0.6038.01%0.5241.33%0.4735.49%m
eps - basic (p)1.60 1.10 1.00 1.00 
eps - diluted (p)1.60 1.10 1.00 1.00 
dividends per share- - - - 

Biotech Growth Balance Sheet

 31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)
LSE:BIOG:Liabilities+EQLSE:BIOG:AssetsLSE:BIOG:Liabilities+EQLSE:BIOG:AssetsLSE:BIOG:Liabilities+EQLSE:BIOG:AssetsLSE:BIOG:Liabilities+EQLSE:BIOG:Assets
 31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)
ASSETS
fixed assets fixed assets--%--%--%--%m
intangibles intangibles--%--%--%--%m
fixed investments fixed investments461.3899.97%445.6799.91%431.1799.99%398.6699.37%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors0.120.03%0.410.09%0.060.01%2.530.63%m
cash & securities cash & securities--%--%--%--%m
TOTAL461.49100%446.07100%431.23100%401.19100%m
LIABILITIES
creditors - short creditors - short14.323.10%28.686.43%22.365.18%35.628.88%m
creditors - long creditors - long--%--%--%--%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL14.323.10%28.686.43%22.365.18%35.628.88%m
EQUITY
ord cap, reserves ord cap, reserves447.1896.90%417.4093.57%408.8894.82%365.5791.12%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL447.1896.90%417.4093.57%408.8894.82%365.5791.12%m
OTHER
NAV Basic800.80 747.50 786.80 932.40 
NAV Diluted800.80 747.50 786.80 932.40 

Biotech Growth Cash Flow Statement

31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)
Operating CF-5.29-4.11-4.40-3.77m
Pre-Financing CF52.79-11.91-41.4087.17m
Retained CF23.1113.08--m

Biotech Growth Brokers

NameActivityTypeMnemonicCode
Arbuthnot Securities LimitedMarket Maker(MMF)Broker/DealerARBTALESGB31MKT
J.P. Morgan Cazenove LimitedMarket Maker(MMF)Broker/DealerCAZRCAZEGB2L
Cenkos Securities PlcMarket Maker(MMF)Broker/DealerCNKSCNKOGB21
Collins Stewart Europe LimitedMarket Maker(MMF)Broker/DealerCSCSCSTEGB21
J.P. Morgan Securities LtdMarket Maker(MMF)Broker/DealerJPMSJPMSGB2L
UBS AGMarket Maker(MMF)Broker/DealerUBS.UBSWGB2LEQU
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
LSE
BIOG
Biotech Gr..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201125 09:24:18